+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Inotropic Agents Market Report 2025 - Product Thumbnail Image

Inotropic Agents Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
Cancer biologics Market Report 2025 - Product Thumbnail Image

Cancer biologics Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Therapeutic Proteins Market Report 2025 - Product Thumbnail Image

Therapeutic Proteins Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
From
From
Ischemic Stroke - Pipeline Insight, 2025 - Product Thumbnail Image

Ischemic Stroke - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Global Cancer Immunotherapy Market Analysis & Forecast to 2025 - Product Thumbnail Image

Global Cancer Immunotherapy Market Analysis & Forecast to 2025

  • Report
  • November 2020
  • 450 Pages
  • Global
From
Targeted Oncology Therapeutics: Hematology Cancers - Product Thumbnail Image

Targeted Oncology Therapeutics: Hematology Cancers

  • Report
  • October 2021
  • 110 Pages
  • Global
From
From
From
Acute Ischemic Stroke- Pipeline Insight, 2025 - Product Thumbnail Image

Acute Ischemic Stroke- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator